Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics

Inclusion Criteria: * Diagnosis of schizophrenia * Treatment with one atypical antipsychotic\* (for a first/new episode or a switch of therapy) for at least 2 weeks and maximum 8 weeks prior to the first study visit. * Patient takes an AAP according to local SPC and current medical practice * The patient must be able to understand and comply with the study requirements as judged by the investigator, e.g. patient must be able to read and write Exclusion Criteria: * Treatment with an additional AAP or AP to the initial prescribed AAP within the 2-8 weeks before the patient is included in the study * Since the use of clozapine is limited, due to, among other things, the risk for agranulocytosis, patients on treatment with this '2nd line'AAP are excluded. * Previous enrolment or treatment in the present NIS * Known allergy to the prescribed AAP or any of its substances